Erlotinib-Loaded Dendrimer Nanocomposites as a Targeted Lung Cancer Chemotherapy

Lung cancer is the main cause of cancer-related mortality globally. Erlotinib is a tyrosine kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of oncological nanotechnology has provided a novel drug delivery system for erlotinib. The aims of this current invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatani, Wafa K., Aleanizy, Fadilah S., Alqahtani, Fulwah Y., Alanazi, Mohammed M., Aldossari, Abdullah A., Shakeel, Faiyaz, Haq, Nazrul, Abdelhady, Hosam, Alkahtani, Hamad M., Alsarra, Ibrahim A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180382/
https://www.ncbi.nlm.nih.gov/pubmed/37175381
http://dx.doi.org/10.3390/molecules28093974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180382/
https://www.ncbi.nlm.nih.gov/pubmed/37175381
http://dx.doi.org/10.3390/molecules28093974

Ejemplares similares